Gevokizumab Suspended Phase 2 Trials for Rheumatoid Arthritis Treatment

IndicationsStatusPurposePhase
SuspendedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00777816Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis